LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...
Insurance Coverage on Vivos Appliances and Treatment Now Available to a Significant Number of Nevada Patients Previously Unable to Access Coverage Concurrently, Vivos Implements Cost Reduction ...
LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...
On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and ...
vivo today announced the global launch of vivo OriginOS, the company’s other operating system used outside of North America. I’ve been a huge fan of vivo for a few years now, and the X200 Pro is one ...
Full Year 2025 revenue increased 16%Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, ...
Android 15 is coming later this year, but people are already very excited about it as the new OS will bring several exciting features that Android users have been requesting for a long time. I have ...
Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions, today announced the submission of its Investigational Device ...
Vivos Therapeutics, Inc. announced it will release its first quarter 2025 financial results on May 15, 2025, after market close, followed by a conference call at 5:00 p.m. ET to discuss the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results